Literature DB >> 528776

Correlation of platelet taurine levels with thyroid function.

S I Baskin, S J Klekotka, Z V Kendrick, D G Bartuska.   

Abstract

Changes in neurotransmitter or neuromodular activity and levels have been thought to be responsible for some of the behavioral characteristics observed in patients with thyroid disease. To investigate these relationships, taurine, a proposed inhibitory neurotransmitter or modulator, was measured in platelets, which may serve as biochemical model for synaptosomes. Blood of euthyroid, hypothyroid and hyperthyroid patients was collected. Thyroxine was determined by RIA. Platelets were separated using differential centrifugation techniques. The taurine in platelets was separated by ion exchange chromatography and was assayed spectrophotometrically as a product produced by coupling with dinitrofluorobenzene. In hypothyroid, untreated hyperthyroid and euthyroid individuals, taurine/platelet and number of platelets/ml of blood were inversely related. In propranolol-treated hyperthyroid patients, such a relation was not found. Following initial treatment with either antithyroid drugs (i.e. methimazole or propylthiouracil) and/or propranolol, taurine/platelet returned to euthyroid levels while plasma thyroxine levels remained elevated. These data implicate a relationship between taurine in platelets and the thyroid state in man.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528776     DOI: 10.1007/BF03350410

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

Review 1.  Possible functions of taurine in the central nervous system.

Authors:  S I Baskin; A J Leibman; E M Cohn
Journal:  Adv Biochem Psychopharmacol       Date:  1976

2.  The excitation and depression of spinal neurones by structurally related amino acids.

Authors:  D R CURTIS; J C WATKINS
Journal:  J Neurochem       Date:  1960-09       Impact factor: 5.372

3.  Effects of taurine on psychomotor activity in the rat.

Authors:  S I Baskin; D L Hinkamp; W J Marquis; H A Tilson
Journal:  Neuropharmacology       Date:  1974-07       Impact factor: 5.250

4.  Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement.

Authors:  P C Whybrow; A J Prange; C R Treadway
Journal:  Arch Gen Psychiatry       Date:  1969-01

5.  The effects of acute administration of propranolol and practolol on the uptake, content, release, and turnover of noradrenaline in the rat heart in vivo.

Authors:  B Lemmer; R Saller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Metabolic effects of norepinephrine on the heart in relation to the functional status of the thyroid.

Authors:  J J Spitzer; M Gold; A N Miller; J C Scott
Journal:  Metabolism       Date:  1968-08       Impact factor: 8.694

7.  Effect of taurine on calcium binding to microsomes isolated from rat cerebral cortex.

Authors:  K Izumi; R F Butterworth; A Barbeau
Journal:  Life Sci       Date:  1977-03-15       Impact factor: 5.037

8.  The effect of age on taurine levels in eye tissues.

Authors:  S I Baskin; E M Cohn
Journal:  Exp Eye Res       Date:  1977-03       Impact factor: 3.467

9.  Effects of hypothyroidism and thyroxine substitution on the metabolism of L-methionine, L-cystathionine and taurine in developing rat brain.

Authors:  K Heinonen
Journal:  Acta Endocrinol (Copenh)       Date:  1975-11

10.  Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.

Authors:  G V Born; K Juengjaroen; F Michal
Journal:  Br J Pharmacol       Date:  1972-01       Impact factor: 8.739

View more
  1 in total

1.  Changes in brain size with treatment in patients with hyper- or hypothyroidism.

Authors:  Angela Oatridge; Maria L Barnard; Basant K Puri; Simon D Taylor-Robinson; Joseph V Hajnal; Nadeem Saeed; Graeme M Bydder
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.